Nuclear Factor Erythroid 2-Related Factor 2 and SARS-CoV-2 Infection Risk in COVID-19-Vaccinated Hospital Nurses.

Publication date: Jul 09, 2025

Background/Objectives: The COVID-19 pandemic has caused sickness and death among many health care workers. However, the apparent resistance of health care workers to SARS-CoV-2 infection despite their high-risk work environment remains unclear. To investigate if inflammation and circadian disruption contribute to resistance or diminished susceptibility to the SARS-CoV-2 virus, we retrospectively evaluated a cohort of volunteer hospital nurses (VHNs). Methods: A total of 246 apparently healthy VHNs (mean age 37. 4 +/- 5. 9 years) who had received the BNT162b2 mRNA vaccine were asked to report their sleep quality, according to the Pittsburgh Sleep Quality Index, and number of SARS-CoV-2 infections during the observational study period (from the end of December 2020 to April 2025). The expression of inflammation-associated mediators and circadian transcription factors in peripheral blood mononuclear cells, as well as sleep quality, were examined. Results: Our findings revealed no anthropometric, biochemical, or inflammation-associated parameters but demonstrated significantly greater levels of NFE2L2, also known as nuclear factor erythroid-derived 2-like 2 (NFR2), gene expression in peripheral blood mononuclear cells among VHNs who had never been infected with SARS-CoV-2 (n = 97) than in VHNs with only one (n = 119) or with two or more (n = 35) prior SARS-CoV-2 infections (p < 0. 01). This result was confirmed through one-to-one propensity score matching (p < 0. 01). Moreover, NRF2 gene expression was not associated with the number of COVID-19 vaccinations (p = 0. 598). Finally, NRF2 gene expression was higher among participants who reported better sleep quality (p < 0. 01). Conclusions: Our findings suggest possible interactions among NRF2 gene expression, protection against SARS-CoV-2 infection, and the modulation of COVID-19 vaccination efficacy.

Open Access PDF

Concepts Keywords
Basel anti-S-RBD IgG antibody
Nurses COVID-19
Pandemic healthcare workers
Sleep SARS-CoV-2
vaccine

Semantics

Type Source Name
disease MESH SARS-CoV-2 Infection
pathway REACTOME SARS-CoV-2 Infection
disease MESH death
disease MESH inflammation
disease IDO susceptibility
disease MESH sleep quality
disease IDO blood
drug DRUGBANK Tropicamide
drug DRUGBANK Coenzyme M
disease MESH infections
disease MESH occupational disease
pathway KEGG Circadian rhythm
disease IDO production
disease MESH cytokine storm
disease MESH liver disease
disease MESH heart failure
disease IDO history
disease MESH cancer
disease MESH hepatitis
drug DRUGBANK Melatonin
disease MESH sleep latency
drug DRUGBANK Dextrose unspecified form
disease IDO infection
disease MESH recurrence
drug DRUGBANK Cholesterol

Original Article

(Visited 1 times, 1 visits today)